Home
About
About Anagenics
Board of Directors
Divisions
Our Divisions
Beauty
Brands
évolis®
Uspa
Investors
Investor Centre
ASX Announcements
2024
2023
2022
2021
2020
2019
Financial Information & Reports
Share Registry Information
Analyst Coverage
Share Information
Anagenics in the media
Newsletter Archive
Corporate Governance
Corporate Governance
Board Charter
Code of Conduct
Policies
Audit Committee Charter
Nomination and Remuneration Committee Charter
Performance Evaluation Process
Corporate Code of Conduct
Environmental, Social and Governance Statement
✕
2023
Home
2023
August 22, 2023
Published by
AN1 Marketing
on
August 22, 2023
Categories
Anagenics to Acquire Face MediGroup
June 27, 2023
Published by
AN1 Marketing
on
June 27, 2023
Categories
FY23 Financial Performance and Business Update
June 27, 2023
Published by
AN1 Marketing
on
June 27, 2023
Categories
Appendix 4C and Quarterly Activity Report
June 27, 2023
Published by
AN1 Marketing
on
June 27, 2023
Categories
Notification of cessation of securities – AN1
June 27, 2023
Published by
AN1 Marketing
on
June 27, 2023
Categories
Application for quotation of securities – AN1
June 27, 2023
Published by
AN1 Marketing
on
June 27, 2023
Categories
CEO Appointment
June 27, 2023
Published by
AN1 Marketing
on
June 27, 2023
Categories
Change in substantial holding
June 27, 2023
Published by
AN1 Marketing
on
June 27, 2023
Categories
Change of Director’s Interest Notice x2
June 27, 2023
Published by
AN1 Marketing
on
June 27, 2023
Categories
Application for quotation of securities – AN1
Prev page
1
2
3
4
5
6
Next page